Clinical Trials Browser

Interventional × benralizumab × 30 days × Clear all

NCT04552288 2026-06-01

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase 2 Completed

51 enrolled 8 charts

Other hematologic neoplasm

Hematologic Neoplasms